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Abstract 
 
Water is one of the simplest chemical substances present in nature, 
nevertheless it is the essential element for the life and all living organisms 
are mainly constituted of water. Water is susceptible to be used for 
numerous purposes, including edible, both for humans and animals. 
In the food animal production, drinking water is frequently used as a way 
to carry out the most common pharmacological treatments. In these cases, 
there are many variables which could degrade drugs dissolved in this 
mean, even when properly arranged pharmaceutical formulations are 
used. In fact, although a product obtains a Marketing Authorization 
through appropriate laboratory studies both drug stability and solubility, 
on the other hand the solubility of the same drug in natural water used as 
a drinking water is not documented. In the present study has been 
evaluated the dissolution kinetics (at 0 hours and 24 hours) of products, 
having oxytetracycline and tylosin as active ingredient, used in drinking 
water samples in order to see how the different physical and chemical 
factors that characterize the drinking water may affect therapeutic 
efficacy. In fact, multiple factors, also of little relevance if individually 
considered, are able to adversely affect the pharmacological treatment 
carried out in drinking water. 
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For all based-oxytetracycline products considered, it was possible to 
observe a tendency to decrease in solubility between 0h and 24 h. In fact, 
for the different products, at 24h, active ingredient percentages between 
20 and 62.8% (compared to that ones detected at 0h) were observed. 
About the based-tylosin products, the results were different. In fact, for 
some products was possible to observe a trend of solubility increase 
between 0h and 24h results. At 24h, for all based-tylosn different 
products, active ingredient percentages between 80% and 164% 
(compared to that ones detected at 0h) were detected. Therefore, the 
intrinsic characteristics of the water such as pH, hardness, conductivity 
and calcium may affect the dissolution of drugs tested in water. The 
results suggest that it would be appropriate to test the products in water 
samples under challenging conditions dissolution, in order to identify in 
advance possible problems.  
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1. Background 
 
Water is one of the simplest chemical substances present in nature, 
nevertheless it is the essential element for the life and all living organisms 
are mainly constituted of water. Water is susceptible to be used for 
numerous purposes, including edible, both for humans and animals. 
Therefore, by law, water must meet specific chemical, physical and 
microbiological characteristics. In the food animal production, drinking 
water is frequently used as a way to carry out the most common 
pharmacological treatments (Zaghini A., 2005). The oral medication by 
drinking water offers different advantages. In situations of disease, feed 
intake decreases. Water intake is also affected, although to a lesser extent. 
In fact, water consumption decreases 30% in situations of disease, whilst 
feed consumption decreases 40%. Water consumption also returns to 
normal levels much more quickly than feed consumption (Pijpers A. et 
al., 1991).  
Furthermore, in contrast to medicated feed in feed bins, there is no 
dilution effect with drinking water. This makes dosage periods shorter 
and yields considerable economic and safety benefits, as withdrawal 
periods can be adjust more precisely. While with medicated feed, the 
product must first be ordered, then mixed and finally delivered to the 
farm, therapy by drinking water can start more quickly. Medicated 
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drinking water allows quick action when there is a disease outbreak and 
prevents loss of animals and deterioration of zootechnical parameters 
(Kunesch et al., 1986).  
Studies have shown that a drug’s bioavailability is greater when it is 
supplied in water than in medicated feed. The maximum absorption of 
drugs takes place in the small intestine. With gastric digestion, the 
stomach empties liquid contents faster than solids. Consequently, water-
dissolved medicines are absorbed more quickly than medicines that have 
to be extracted from the food and dissolved by the digestive juices before 
they can absorbed (Reeve-Johnson L., 1998).  
In the oral medication by the drinking water, there are many variables 
(for instance hardness, temperature, pH of the water and characteristics of 
mixing and distribution of the drugs) which could degrade drugs 
dissolved in this mean, even when properly arranged pharmaceutical 
formulations are used. The drugs solubility in the drinking water is a 
critical and challenging factor for the therapy. In fact, if the medication 
does not dissolve, its active ingredients will not be completely released 
and the animals will not receive an effective dose (Zaghini A., 2005). 
The present study evaluates the dissolution kinetics of some veterinary 
drugs commonly used in drinking water for food animals bred in 
zootechnical farms. The aim of the study was to assess how the 
therapeutic efficacy might be affected by different factors that 
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characterize drinking water. In fact, there are multiple factors, even with 
little relevance when individually considered, which are responsible to 
make the pharmacological treatments virtually useless. These factors 
combine to modify the stability and/or solubility of individual active 
principles, or the formulation used, as well as excipients present in 
drinking water (Almond G. and Monahan K, 2011).  
Furthermore, it is extremely important to consider the correct modality of 
mixing the veterinary drugs in water by the operators and the 
functionality both of the blending plant and the water distribution system 
in the farm, especially when the veterinary drugs used are poorly hydro 
soluble (Dorr P.M. et al., 2009).  
Finally, after the administration of the medicated water, it is absolutely 
critical to clean carefully the whole water distribution system in order to 
avoid that residues of the administered drugs could remain adherent to the 
internal walls of the plant tubes. In fact, these residues can be released 
again reaching animals in sub therapeutic doses or interfering in any way 
(chemical, dynamic, kinetic etc.) with following pharmacological 
treatments implemented by drinking water (Croubels S. et al., 2001). 
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2. Water and its characteristics 
 
The water also known as Dihydrogen monoxide, H2O, is defined as: 
"clear, colorless, odorless and tasteless liquid "(USGS, 2013). Water has 
a molecular weight of 18 Daltons and is constituted by one oxygen atom 
and two hydrogen atoms. Water is totally neutral, however, due the 
presence of oxygen, this molecule is polar and has a strong tendency to 
form hydrogen bonds (each water molecule can form hydrogen bonds 
with other four molecules of water) (A. F. I., 1991). Water is the essential 
element of life, all living organisms are mostly made up of water and life 
on Earth, in all its forms known, uses the physical and chemical 
properties of the water for its own existence. Flowing above and below 
the earth's surface, water make both its chemical function of soluble salts 
or minerals dissolution and its physical function of insoluble materials 
entrainment; moreover, water is able to incorporate gas, such as oxygen 
and carbon dioxide, allows that the animal life can take place in rivers, 
lakes and seas as well. The primary source of water is atmosphere 
because its precipitation (Figure 1). When the water is collected on the 
soil, it is a solution with a composition that could be extremely variable 
depending with both of the function of the substances which take contact 
with it and the time and physical modalities of the contact when it occurs.  
The primary sources of water can be classified as follows: 
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1. Meteoric water (rain, snow, hail); 
 
2. Surface water (rivers, lakes, seas, oceans, etc.). 
 
3. Groundwater (phreatic layer, aquifer layer). 
 
 
Figure 1. Water cycle (United States Geological Survey, 2013). 
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Some chemical and physical characteristics of the pure water 
(http://www.62.co.za/water_properties.html).  
- Melting point with normal pressure….……………………………0°C  
- Boiling point with normal pressure…....………………………..100°C  
- Specific weight at 0°C (water)…......……………………0.9998 g/cmc  
- Specific weight at 3.98°C……….………………….……….....1 g/cmc  
- Specific weight at 20°C…………………………………..0.9982 g/cmc  
- Specific weight at 0°C (ice)……….........…….………….0.9168 g/cmc  
- Specific heat at 15°C (water)………...………………………….1 cal/g  
- Specific heat at 0°C (ice)…………….............………….…0.4870 cal/g  
- Specific heat at 100°C (vapor)…....……....……………...0.4620 cal/g  
- Dipole moment…....…………………………………..…...1.84x10-18  
- Viscosity at 0°C……………………………………………0.0179 poise  
- Viscosity at 20°C…………………………………………..…0.01 poise  
- Viscosity at 100°C………………………………………...0.0028 poise  
- Coeff. of compressibility (T and P normal).………….…4x10-5 cmq/kg  
- Constant dielectric at 18°C………………………….....81.07 Farad/m  
- Eletric conductivity at 18°C……………………………3.8x10-8 S/cm  
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2.1 Quality of drinking water 
 
The groundwater can be:  
 
1) Phreatic. This kind of water is less valuable because can be easily 
reached by infiltrant pollutants;  
 
2) Deep. This kind of water offers the best requirements of quality of 
drinking water because passing trough underground layers of soil, 
is deeply filtered and properly purified.  
 
Drinking water must meet precise organoleptic, bacteriological, physical 
and chemical requirements. The Presidential Decree n. 236 of May 24, 
1988 (and subsequent updates) has enacted EEC Directive 80/778 
concerning the quality of water intended for human consumption: 
"Water for human consumption are intended all waters, irrespectively of 
the origin, in which state they are or after processing, supplied for 
consumption; furthermore water for human consumption are all water 
used by food businesses by acquisition or contact for the manufacture, 
treatment , storage, placing on the market of products and substances 
intended for human consumption and which may have consequences for 
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the health of the final food product. Are excluded from this decree, the 
mineral and thermal waters".  
This is the broadest definition of drinking water because it includes all the 
different possibilities of use of water for edible or for multiple purposes. 
This Presidential Decree, as well as to extend the concept of drinking 
water according to its use, it gives also a precise definition of drinking 
water. Infact, there are over than 60 parameters to classify waters 
destined for human consumption, and most of these parameters regards 
physical characteristics.  
Legislative Decree n. 31 of 2 February 2001, implementing Directive 
98/83/EC, regulates the quality and ensure healthiness of water intended 
for human consumption in order to protect human health from the adverse 
effects of any contamination of water": 
 
1) the treated or not treated waters, intended for drinking use, for the 
preparation of foods and beverages, or other domestic purposes, 
regardless of their origin, even if distributed through an acqueduct, from a 
tanker, from bottles or containers; 
 
2) waters used in any food-production to preparing, processing, 
preservating or marketing products or substances intended for human 
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consumption (excluding those identified under Article 11, paragraph 1, 
letter s), which quality not affects the foodstuff healthyness. 
In the past the risk was standed mainly by contaminated water, and 
sometimes exclusively by infections, today due the increasing of 
pollution sources caused by technological evolution, changing needs and 
living conditions, there is a considerable spread of chemicals in the 
environment with the consequent change of the water pollution type 
(calcium, magnesium, iron, manganese, silica, carbon dioxide, hydrogen 
sulfide, phosphate, copper, aluminum, arsenic, lead, cadmium, nitrates, 
algae, protozoa, etc.). 
The following Table 1 and Table 2 summarize the possible substances 
present in water and the parameters useful as indicators of its quality. 
In short, the main characteristics of water that must be kept under control 
are essentially: hardness, pH (acidity and alkalinity) and nitrites. 
  
17 
 
PHYSICAL 
STATE 
SOURCE 
Inorganic Organic Biologic system 
 
 
Solution 
 
Inorganic salts of 
Na
+
, Ca
2+
 , NH
4+
, 
NO
2-
, NO
3-
, Cl
-
 , 
Mg
2+
, etc.  
 
Radioactive ions 
 
Gases: O2, N2, CO2, 
NH3, H2S, etc.  
 
Quaternary 
ammonium-based  
 
Artificial corrective 
systems: 
pesticides, 
fertilizers, 
herbicides, etc.  
 
Organic salts 
 
 
Organic 
decomposition 
 
Dispersion 
suspension 
emulsion, 
colloid 
 
Erosion and/or 
corrosion products: 
sand,  
insoluble salts, 
etc. 
 
Treatment residues 
 
Micelles or large 
molecules (S, SiO2, 
Fe2O3, Al2O3, etc.)  
 
Immiscibles liquids 
 
Insoluble products  
 
Treatment residues 
 
Macromolecules  
 
Surfactants 
 
Humic acids 
 
 
Microorganisms  
 
Algae  
 
Macromolecules 
Table 1. Possible substances in the water (2).  
 
  
18 
 
PARAMETER QUALITY INFORMATIONS 
Cations and anions  
Specific conductivity 
Dissolved solids 
Hardness (Ca and Mg)  
 
Geochmica degli strati attraversati  
Water salinity 
Organic variability of water 
Geochemistry of crossed layers  
 
NO2, NO3, NH3 total Nytrogen  
(Nytrogen cycle)  
PO4 totale phosphorus 
(Phosphorus cycle)  
 
Inorganic and biologic pollution 
Dissolved oxygen  
 
 
Oxidation  
Well-being of acquatic life 
pH  
 
 
Acidity and corrosivity  
Well-being of acquatic life 
Radioactivity  Radiochemistry 
 
Total carbon  Presence of organic substances 
 
Pesticides  
Organic solvents  
Presence of organic substances 
Ecological status  
 
Turbidity  
Temperature  
Color, odor  
Physical state  
 
 
B.O.D.(Biochemical oxygen demand)  Organic pollution  
 
Microorganisms  Human and animal pollution  
 
Table 2. Water quality parameters (A.F.I., 1991).  
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2.1.1 Hardness  
 
In nature, usually, the water hardness is determined usually from the 
substrate where it flows. Chemically, the water hardness occurs by 
measuring the presence of metal ions such as calcium and magnesium 
salts dissolved in the water itself. 
The hardness is distinguished in:  
 
- temporary or carbonic hardness, due by Ca and Mg soluble 
bicarbonates that, at boiling water temperature, pass to insoluble 
carbonates: 
 
Ca (HCO3)2 → CaCO3 ↓ + H2O + CO2 ; 
 
- permanent or non-carbonic hardness, due by other salts of Ca 
and Mg (sulfates and chlorides mainly) that remain in solution 
even after a prolonged boiling of water; 
 
- Total hardness is the sum of temporary hardness and permanent.  
 
Hardness is measured in hydrotimetric degrees: French degrees (°F) and 
German degrees (°DH), where 1°F = 0.56 °DH (see Table 3): 
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CLASSES 
HARDNESS 
(°F) (°DH) (°e) (°a) 
1°) 
1 
8 
0,56 
4,47 
0,7 
5,6 
0,58 
4,60 
2°) 
12 
20 
6,71 
11,18 
8,4 
14,0 
7,00 
11,60 
3°) 
24 
32 
13,42 
17,89 
16,8 
22,4 
13,90 
18,50 
4°) 
36 
40 
20,13 
22,36 
25,2 
28,0 
20,90 
25,20 
Table 3. Natural water classification (A.F.I., 1991). 
(°e) = English degree  
(°a) = American degree 
 
2.1.2 pH (acidity and alcalinity)  
 
In freshwater, the pH ranges between 6.5 and 7.5 usually. The pH scale is 
logarithmic, thus the increase by one unit represents 10-fold the acidity or 
alkalinity increase. 
 
2.1.3 Nitrites  
 
The nitrites are derived from the ammonia conversion during the nitrogen 
cycle (Figure 2). Nitrites are transformed into less harmful nitrates. 
Nitrites and ammonia are signs of water pollution. 
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Figure 2. Nytrogen cicle (www.eo.ucar.edu, 2013) 
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2.2 Water quality in the livestock breeding 
 
Water should be considered as an outright food since it is necessary and 
irreplaceable to the animals’ survival. The water intake must even be 
done regularly. In fact, while for other nutrients (eg fat), animals are able 
to accumulate own reserves, water instead must be ingested daily. 
Typically an animal ingests a double water quantity compared to the 
consumed food (Canadian Water Quality Guidelines for Livestock, 
1987). 
The water used for livestock breeding has different origin: aqueduct, well, 
lake, river etc. 
In the poultry, rabbit and swine breeding as well as other livestock 
species, several drugs, especially antibacterial, with different therapeutics 
purposes, are administered. Usually the most important administration 
route is the oral one, via food, but most often via drinking water (Adams 
H.R, 1999). 
The most commonly drugs used via drinking water are the following: 
 
1) antibacterial:  
- Gentamicin;  
- Spiramycin;  
- Tylosin;  
- Tiamulin;  
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- Colistin;  
- Amoxicillin;  
- Sulphadimethoxine-Trimethoprim;  
- Chlortetracyclin;  
- Oxytetracyclin;  
- Doxycyclin;  
2) Acetyl-salicylic acid;  
3) Levamisole;  
4) Vitamin K and B;  
5) Acidifying agents: acetic acid, copper, etc;  
6) Disinfectants: chlorine, hydrogen peroxide, etc;  
7) Yeast.  
 
Particularly the antibacterial use may depend on the need to obtain a 
therapeutic, prophylactic and methaphylactic action (Lawhorn B., 1998).  
In the livestock breeding the drug administration with drinking water is 
an excellent and inexpensive way to carry out a drug treatment. In fact, 
the water "medication" allows to act very quickly and to obtain 
therapeutical effective levels with limited cost and with a little animal’s 
"handling". In addition, in case of diseases (especially diarrhea and 
pneumonia), the animals might eat less, or stop eating completely, while 
they will always continue to drink water.  
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Finally, in case of some drugs (eg sulphanomides), the product powder is 
characterized by a remarkable electrostaticity, then these type of product 
tend to remain on the feeders surfaces, on the structures floors and in the 
air. Consequently, there is a very high risk of cross-contamination and 
carryover (Schneider P., 2003).  
Other antibacterials (eg tetracyclines) because their strong chelating 
activity towards ions like calcium and iron, when added to the feed 
frequently give rise to chelates inactive and nonadsorbable at intestinal 
level (Kunesh J. et al., 1986). Accordingly, a highest quality of the 
drinking water is a very critical factor for the livestock production 
efficiency and health.  
There are multiple and different factors that can determine water quality: 
 
 Biological factors: presence of bacteria, protozoa (coccidia), 
intestinal helminths eggs, etc. For example, a high level of 
coliforms may indicate faecal contamination of the water (in 
general, the drinking water used for livestock should contain fewer 
than 100 total bacteria / ml and less than 50 coliforms / ml). Low 
levels of contamination can be managed using disinfectants 
(usually chlorine-based). 
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 Physical factors: color, taste, odor, clarity; water should be clear 
and odorless. 
 
  Chemical factors: total dissolved solids (TDS), pH, iron, 
hardness, and nitrates/nitrites. 
 
In detail, Total Dissolved Solids (TDS) represent a measure of the 
inorganic substance total concentration present and dissolved in water. 
Usually constitutes the "salinity" because water is determined from 
calcium, magnesium and sodium, in form of bicarbonates, chlorides or 
sulphates, and traces of iron, manganese and other molecules (Table 4) 
(Van Heugten E., 2011).  
The consequences of lower water quality are:  
 
 Presence of bacteria: diarrhoea, mastitis, metritis, abortion, etc.  
 pH, hardness: cystitis, nephritis, metritis, locomotor disorders, etc.  
 Too high level of nitrates: renal and reproductive problems, 
nervous disorders, low milk production, etc.  
 Too high level of iron: obstruction of pipework, etc.  
 Too high level of sulphates: laxative effect, etc.  
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Poor water quality will not always lead to problems in animals, but it 
might affect the efficiency of a water medication. 
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Inorganic substance 
concentration (mg/L) 
Information 
<1.000  
No risk  
 
1.000-2.999  
Acceptable. Mild diarrhea in animals not 
used to this drinking water may occur.  
 
3.000-4.999  
Acceptable. Temporary denial of water 
and mild diarrhea may occur.  
 
5.000-6.999  
Sufficiently healthy, but to be avoided in 
pregnant and lactating animals.  
 
7.000-10.000  
Unsuitable for swine production. Pregnant 
and lactacting females and very young and 
stressed animals are particularly at risk. 
 
>10.000  
To be avoided. 
 
Table 4. Water salinity (Van Heugten E., 2011). 
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2.2.1 pH 
 
The range of acceptable pH values is from 6.5 to 8.5. PH values lower 
than the lowest (acidity) or above the highest (alkalinity) can cause pipes 
corrosion and consequently water could be contaminated by metals such 
as iron, copper, lead and cadmium. A high pH gets worse chlorination 
efficiency. By contrast, a low pH may cause precipitation of some 
antimicrobial agents administered through the drinking water. 
Sulfonamides lose their water solubility in acid pH values (Van Heugten 
E., 2011). 
Water with pH lower than 5.5 can be harmful causing digestive and 
urinary tract problems, demineralization and skeletal fragility, materials 
corrosion. Often a low pH and a low hardness are associated and 
synergistically act on the mobilization of calcium from bones (Dorr P.M., 
2005). 
 
2.2.2 Hardness 
 
As previously reported, water may be considered soft, hard and very 
hard. In general, the water hardness is a problem for the water 
distribution systems (build-up of deposits) especially for the inactivation 
of some antibacterials (for example: tetracyclines can form chelates, 
which may alter their effectiveness, as they cannot be absorbed in the 
presence of divalent ions such as calcium, magnesium and iron) (Kunesh 
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J. et al., 1986) that could prejudice both animal health and the livestock 
performance. In this regard, the following considerations apply: 
 
- from15 to 50°F water is considerated potable;  
 
- above 20 ° F it is possible to have:  
1. Oligoelements intestinal absorption decreased (reduction effect of 
the solvent power);  
2. Reduction in the effectiveness of disinfectants used in solution; 
3. Dissolved salts precipitation if water is heated to above 50 ° C; 
 
- Below 8 ° F drinking water is not suitable for animals and is 
considered aggressive towards metals. 
 
2.2.3 Chlorides 
 
If chloride are present in quantities greater than 250-500 ppm can give to 
the water an unpleasant taste and then make it unpleasant to animals (Van 
Heugten E., 2011); often chlorides accompany the organic matter of 
animal origin and therefore may indicate pollution. It can not exclude the 
possibility that high concentrations may interfere on rumen fermentation. 
Avian species are also very sensitive to sodium chloride that is 
nephrotoxic. 
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2.2.4 Iron 
 
 The presence of iron in water can enhance the growyh of certain bacteria, 
which can result in the precipitation of ferric derivates. Although this 
does not affect animal health, however, iron quantities of 2-3 ppm may 
block drinking nozzles. At concentrations of 5 ppm or more, 
oxytetracycline and its derivates form chelates, which prevent its 
absortion. Finally concentrations higher than 10 ppm lead animals to turn 
down the water (Van Heugten E., 2011). Apramycin should not be used 
in water with a high ferric content, as it may form chelates, which will 
limit its therapeutic effectiveness (Manual of water medication, 2011). 
 
2.2.5 Sulfates 
 
Any activity laxative/purgative. Sulfates can cause diarrhoea in weaning 
piglets especially, but in adults as well; sulfates may be associated with 
bacterial contamination(Van Heugten E., 2011). 
 
2.2.6 Nitrates and nitrites  
 
Have a dual origin: organic matter degradation, leaching of soil after 
animal manure spreading and fertilizers. Beyond certain concentrations, 
nitrates have an own toxicity (growth retardation, digestive problems, 
decrease in the eggs deposition), but their danger remain mainly in the 
possibility to be converted into nitrites (especially in the cattle rumen), 
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very toxic for their action to formate methaemoglobin which makes it 
impossible to transport oxygen to the tissues. The maximum allowable 
concentration for nitrates is only 0.1 mg/l (Arduin M., 2004). 
 
2.2.7 Ammonia 
 
Ammonia is within the standards for drinking water but coming from 
organic matter can oxidize to nitrates (Arduin M., 2004). 
 
2.2.8 Manganese 
 
Beyond to abnormal flavors, a very high pH, can cause damage to the 
equipments (Arduin M., 2004). 
 
2.2.9 Phosphorus 
 
Phosphorus may have a chemical (e.g. fertilizers) or organic (e.g. 
manure) origin. Phosphates associated with bacterial pollution makes the 
water undrinkable (Arduin M., 2004). 
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Parameters Maximum Allowable 
Concentration  
Nitrates (mg/l NO3) 
Nitrites (mg/l NO2) 
Ammonia (mg/l NH4) 
Iron (pg/l Fe) 
Manganese (µg/l Mn) 
Copper (µg/l Cu) 
Phosphorus (µg/l P205) 
50 
0,5 
0,5 
200 
50 
1000 
5000 
Table 5. Legal parameters for certain undesirable substances  
(Arduin M., 2004). 
 
Evidently, when the drinking water features does not meet the desired 
ones, it is not possible to carry out multiple and different therapeutic 
treatments. 
The major obstacles encountered in using drinking water as "vehicle of 
drugs" are represented by water solubility and drug stability in water. To 
facilitate a perfect solubility of the active ingredients, the commercial 
formulations contain particular excipients and/or salified forms soluble in 
water.  
Excipients most frequently added to the formulations to be used in water, 
beyond to facilitate dissolution of the active ingredient, can play a role in 
protection it as well. 
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In general excipients comprise:  
 
- Antioxidants  
- Buffer sistems  
- Chelating 
- Colorants  
- Glidants 
- Flavoring  
- Preservatives  
- Disperdants.  
 
In any case, beyond any consideration of the complete and rapid 
formulation dissolution, must also be evaluated with particular attention 
the characteristics of the water distribution system where the product 
dissolution takes place. In fact, the system might influence the dissolution 
kinetics of the drug, with a possible incomplete dissolution that would 
lead to a reduced oral bioavailability and consequently sub-optimal 
hematic concentrations (Allen L.V. Jr, 2001). Therefore, it is very 
important to constantly verify the concentration both in the water in 
which the drug is dissolved and in the water at the level of the drinking 
troughs, in order to avoid an under-dosed drug and/or a subsequent 
solubilization of the precipitates with the possibility of a following cross-
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contamination. This last case would involve, consequently, the presence 
of undesirable active substances in animal products (EMA, 2002). 
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3. Solubility of veterinary drugs 
 
The solubility of a medication will depend on the product (active 
substance and excipients) and the water quality. As described by Marco 
E. (2009) the product’s active substance must be able of ionizing in order 
to be water-soluble; otherwise it would precipitate out to form sediments. 
An example of a compound able of ionizing upon contact with water 
would be a salt, and this is the most common presentation of soluble 
medications. A salt will separate into two kinds of radicals: acid 
(positive) and base (negative). Not all compounds used will separate and 
give the same amount of acid and base radicals. This characteristic is 
expressed by means of the pKa constant (Manual of water medication, 
2011). 
The smaller this constant, the more acidic the compound. So, a compound 
with a pKa of 2.7 (the pKa of phenoxymethylpenicillin), will be 
considered as an acid, while a compound with a pKa of 7.6 (the pKa of 
lincomycin) will be considered as a base. When the pH of the medium in 
which it is dissolved coincides with its pKa value, the compound will be 
50% ionized. For a correct solution, there should be full ionization. Thus, 
a compound that has a weakly basic character will be ionized better in 
water with a acidic pH, for example water from granite soils, while a 
36 
 
compound with a weakly acidic character will ionize better in a basic 
medium, for example water from calcareous soils (Marco E., 2009)  
In practice, slightly acidifying or neutralizing drinking water may be of 
great value to achieve better solubility of thr products used. Thus, for 
example, to avoid problems with weakly basic compounds, such as 
tetracyclines, acidification of drinking water can be recommended. 
To know the substances solubility is crucial, but it is not always easy to 
understand why a certain substance is less or more soluble in a specific 
solvent, since there are multiple factors that affect solubility and that 
often act contrasting each other. When we use the term "solubility" tacitly 
assume that it is the solubility equilibrium (Marco E., 2009). 
In other words it is assumed that a solid (solute) is put in contact with a 
liquid (solvent), that the system is mantained under agitation until a state 
of equilibrium is reached. This equilibrium state is characterized by the 
fact that the solute concentration has reached a constant level. 
In general there are several equilibrium situations:  
 
- the solid phase is a pure compound and there is only one liquid 
phase; 
- the solid phase is a pure compound and is present more than one 
liquid phase; 
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- two components form a solid solution so that there is an unlimited 
solubility in the solid phase;  
- there are two solid solutions that are formed, in this case the 
solubility in the solid phase is limited. 
 
Among the above possible situations, the first one is most common. The 
solubility of a solid is determined putting in contact a considered 
excessive quantity of this solid with a solvent, in an airtight container, at 
a predetermined and constant temperature, up to the achievement of an 
equilibrium state.  
Conventionally 72 hours are considered necessary to achieve this state. 
Using less time, the solubility can be determined by extrapolation, it 
means by constructing a curve taking samples from the medium every 12 
hours and testing the concentration of the solute. If the compound is not 
very stable in aqueous solution it is necessary to use a different method 
that provides for faster results, such as not to allow the product to 
deteriorate (sampling every 20 minutes), and finally calculate results by 
the Nogami method. 
The solubility is commonly expressed as molality, or as weight of solute 
per gram of solvent. 
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3.1 Temperature effect 
The heat associated to the solution of a drug substance in solid form in a 
solvent (usually water) shows that the solubility is conditioned by the 
temperature. If during the dissolution heat will develop, the compound 
solubility decreases with increasing temperature, and in general, in simple 
cases, the opposite will occur. It is well known that when KOH is 
dissolved in water develops a lot of heat develops; but this doesn’t mean 
that the solubility of the compound decreases with temperature. Indeed, 
the energy that is initially developed as heat is positive, but overall at the 
end when it reaches the saturation point it becomes negative, therefore 
actually, an increase in temperature leads to a further increase of the 
solubility. 
 
3.2 Electrolytes effect 
In aqueous solution the present electrolytes can greatly affect the 
solubility of a compound, particularly if the compound itself is an 
electrolyte. 
 
3.3 Use of mixed solvents 
The solvent used has considerable influence on the solubility and it must 
always to be specified. Often in pharmacology it is necessary to use 
mixed solvents to solubilize poorly soluble substances in water. The co-
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solvents most commonly used are ethanol, propylene glycol, glycerin, 
polyoxyethylene glycol. 
 
3.4 Dielectric costant effect  
Frequently, the solubility is a function of the medium dielectric constant, 
and the relationship is described generally by the Jaffe equation:  
ln [S] = (A / ε) + B  
Very often the solubility of hydrophobic substances decreases with the 
medium dielectric constant increase. 
 
3.5 Solubility multiple peaks (Chameleonic effect) 
For certain substances in certain mixtures of solvents is possible to 
observe multiple peaks in the graph that represents the solubility as a 
function of the solubility parameters of solvents. 
 
3.6 Complexes formation 
Substances can form complexes with complexing agents. In general, one 
of the two components of the system is defined substrate, while the other 
component is defined ligand. 
This phenomenon is often associated with problems of solubility in the 
pharmaceutical field, but can be useful in the production process as well. 
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3.7 Cyclodextrins 
These compounds (α, β and γ in relation to their size ring) form 
compounds with certain substances; cycledextrins hold the whole 
molecule, or some hydrophobic portions of it within their "cavity." This 
affects some physico-chemical properties of the complexed substance 
without affecting its pharmacological properties. 
 
3.8 pH 
As discussed before, the solvent pH influences the solubility of a 
substance which has in its structure acidic or basic groups, shifting the 
balance in one direction or in the opposite one, depending on wheter the 
reaction products or the reagents are incremented. So, use oh pH 
modifiers might affect the solubility of water-soluble antibiotics. 
 
3.9 Mixture of soluble drugs  
As suggested by Dorr P.M. et al. (2009), restrictions on mixing 
medications that may compromise the health and performance of the pigs 
should also be considered. Formation of precipitates when 20-mL 
aliquots of commonly used water-soluble medications prepared according 
to label directions were combined in pairs and observed for 24 hours 
(Table 6). Medications included in precipitation reactions were aspirin 
(ASA), sodium salicylate (Na sal), amoxicillin (amox), sulfamethoxazole-
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trimethoprim (Smz-Tmp), potassium pencillin G (PotPen), neomycin 
(Neo1 and Neo2), tetracycline (tet), oxytetracycline (oxytet), 
chlortetracycline (chlortet), chlortetracycline-sulfamethazine (chlor-S), 
sulfamethazine (sulfa), and tiamulin (tiam). Gentamicin, lincomycin, and 
tylosin were also tested with other products with no observation of 
precipitate formation. 
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Tet Oxytet Chlortet Chlor-S Sulfa Tiam 
ASA             
Na Sal             
Amox             
Smz-
Tmp 
            
PotPen             
Neo 1             
Neo 2             
Tet             
Oxytet             
Chlortet             
Chlor-S             
 
Table 6: Red precipitate; green no precipitate (Dorr P.M. et al., 2009) 
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4. Stability of veterinary drugs 
 
When a medicated solution is stored for a longer time period than 
necessary, it loses quality (palatability and contamination). The optimal 
storage period should correspond to the maximum time during which the 
concentrate remains effective and safe. Poor water quality causes unstable 
products, which leads to low bioavailability, incapacity to optimize active 
substances (affecting both efficacy and safety), failure to respond 
proportionally to the dose, suboptimal dosing and undesirable following 
medication (Manual of water medication, 2011). 
According to the Italian Official Pharmacopoeia, "A medicament is 
considered stable when, in a specific period of time, its essential 
properties do not change or change within tolerable limits, if stored in a 
suitable vessel, under defined conditions of temperature, humidity and 
exposure to light". 
 
4.1 Stability period 
 
Is the period between the preparation of the medication and the time in 
which the medication no longer meets the Official Pharmacopoeia 
requirements. Evidently, in this context, is considered the only chemical 
and physical stability, because the microbiological stability is assured by 
preservative and/or sterilizing treatments. 
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4.2 The time limit t10 
 
It is defined as the required time so that the drug initial title undergoes a 
reduction of 10%. The values are calculated by the stability tests, possibly 
accelerated (http://www.galenotech.org/stabilit.htm; FDA 2013).  
The main causes of instability of medicines are represented by 
temperature, light and humidity. 
 
 Temperature: in general, a temperature increase of 10 degrees 
centigrade increases the rate of chemical reactions of 2-4 times. 
This means that it doubles or even quadruples the drug 
decomposition speed. However, it should be paid great attention to 
the extreme cold, for instance, insulin should be stored in a 
refrigerator, but does not tolerate freezing. In general, it is good 
practice to comply with the storage conditions indicated on the 
packaging and in absence of indications to keep drugs at room 
temperature, between 8 and 25°C. 
 Light: some active ingredients are light sensitive; the packaging 
must be able to protect them from light (eg brown bottles, 
aluminum blisters or opaque) and the packs shall be kept strictly 
closed. Even in the absence of light sensitivity, it is not advisable to 
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prepare in advance the drug dose by pulling it out from the 
container. 
 Umidity: may further a rapid deterioration of medicinal products, in 
general, they should be stored in a dry place. For example, the β-
lactam antibiotics distinctly exhibit this problem and they are easily 
degradable in aqueous environment (fragility and β-lactam ring 
opening, with loss of antibacterial activity) 
((http://www.galenotech.org/stabilit.htm; FDA 2013). 
 
Below are reported some examples of molecules having pharmacological 
action and commonly administered via drinking water, for which some 
expedients are necessaries to avoid affecting the treatment: 
 
 Acetyl salicil Acid. This non-steroidal anti-inflammatory, 
commonly used in swine production, is particularly sensitive to 
sodium carbonate which rapidly hydrolyzes it to salicylic acid with 
complete loss of the pharmacological activity (Moisescu S. et al., 
1975). Must be paid particular attention to the water hardness. 
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 Vitamins K and B1. Both vitamins are characterized by a high 
sensitivity to light and air, respectively, which determine a very 
rapid degradation with loss of activity. Both vitamin K that vitamin 
B1 are inactivated very rapidly by alkaline solutions, while they are 
very stable in acid aqueous solutions (The Merck Index 
Centennials, 1989). It is recommended to prepare solutions 
administered to animals immediately before using; it should be also 
paid particular attention to the integrity of the metal pipes of water 
distribution systems (Carr J., 2002). 
 
 Gentamicin sulfate. This aminoglycoside is characterized by a 
high stability in aqueous solutions from strongly basic ones to 
slightly acidic ones, at room temperature provided in tightly closed 
containers (Osborn E., 1976). Once dissolved in water, the 
gentamicin should not be stored in rusted containers as it is very 
quickly degraded; furthermore, it is good practice to prepare daily 
the aqueous solution to be used (FDA, 2013). 
 
 Bacitracin methylene disalicylate. This antibacterial agent is 
characterized by a good general stability and is not particularly 
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sensitive to changes of pH and temperature. However, the aqueous 
solution that contains it must be prepared daily (FDA, 2013). 
 
 Tylosin. This molecule is characterized by a fairly good solubility 
in water and its solutions are stable in a pH range between 4 and 9; 
for pH values lower than 4 it could occur the formation of a 
derivative (desmicosine) which nevertheless retains unaltered the 
antibacterial activity (The Merck Index Centennials, 1989). 
 
 Oxytetracycline and chlortetracycline. Similarly to most of the 
tetracyclines, are characterized by a good stability at different 
values both temperature and pH, although they are characterized by 
maximum stability at very acids pH (The Merck Index Centennials, 
1989). Likewise to other molecules belonging to this antibacterials 
group, Oxytetracycline and chlortetracycline have propensity to 
form epimers; chlortetracycline, particularly, form epimers 
reversibly at the 4-diethylamino group level. This occurs slowly in 
water, but it is strongly accelerated in the range of pH between 2 
and 6. The antibacterial activity of the epimers is virtually zero 
(Doerschuk A. et al., 1955; McCormack J. et al., 1957). To avoid 
possible changes in the pH of the water, which could be due to 
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tetracycline epimerization, should be paid particular attention to the 
water distribution systems metal pipes integrity. 
 
 Doxycycline hyclate. In an experimental study conducted in field, 
Vervaet C. et al., (2003) evaluated the influence that the early 
addition of citric acid 0.1% (w / v) in water, could have on 
hydrosolubility of doxycycline hyclate. The water samples both 
from the mixer and the troughs were conducted at the following 
points: 0, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 hours after the addition 
of drug. The doxycycline concentrations in the water samples were 
measured with HPLC method. The results obtained showed that the 
tetracycline concentration in water without citric acid addition was 
very low (30 mg/L versus a theoretical concentration of 200 mg/L), 
despite the literature reports as this salt is characterized by a good 
hydrosolubility. The citric acid addition of 0.1% has increased the 
doxycycline concentration in water up to a maximum of 125 mg/L. 
The authors believe that the suboptimal doxycycline concentration, 
even after the addition of citric acid, is caused by the mixer 
structure, probably insufficient for very high water volumes, as 
well as to the dispensing water system because of cohesion of the 
drug on the tubes walls. This study demonstrated, beyond the drug 
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hydrosolubility, the critical importance of all water distribution 
system and how it is always very important to control the drug 
concentrations at various points of the system itself. 
 
 Ceftazidime. Although the β-lactam antibiotics are characterized 
by a high instability in aqueous vehicles, because of the β -lactam 
ring opening, this cephalosporin is characterized by a good 
stability, even in a wide range of concentrations, in aqueous 
solution at temperatures up to 25°C and at pH below 10 (Servais H. 
and Tulkens M.P., 2001). 
 
 Sulfadiazine (sodium) and trimethoprim. With a sulfadiazine and 
trimethoprim powder soluble in water, Vervaet C. et al., (2003) 
evaluated samples of water concentrations of the two antibacterial 
taken both from the mixer and troughs. The water sampling was 
conducted at the following points: 0, 0.5, 1, 2, 3, 4, 7 and 9 hours 
after addition of the two drugs. The concentrations were measured 
using HPLC method. The results obtained have shown that the 
sulfonamide is soluted in water immediately after its addition, 
without requiring particular mixing. The sulfonamide concentration 
remains constant throughout the water distribution system and 
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throughout the experimental period. Conversely trimethoprim 
concentrations appear highly variable and always below the 
theoretical concentration. In fact, much of the drug remains in 
suspension because of its poor solubility in the conditions of use 
(temperature 8°C, pH 8.62). Therefore it would be required an 
optimal mixing system to ensure the best solubility and the best 
possible dispersion of trimethoprim throughout the system. 
 
4.3 Stability of active substance in biofilm 
 
Water quality and poor cleanliness will have an influence both on the 
stability of the medication and on the formation of biofilm. Biofilms are 
complex communities of microorganisms resistant to antibiotics, coated 
with an extracellular polymer that helps them to retain food and to protect 
themselves from toxic agents (Figure 3). The presence of a biofilm in 
water pipework is frequent due to the deficient application of cleaning 
methods. Normally, the purer the product (the less excipients, sugar, etc), 
the lower the production of biofilm, as fewer nutrients are available in the 
pipework. It may be advisable to perform a sensitivity culture of the 
microorganisms present in the biofilm using a sample of the product 
intended for use. An expected result is the maximum halo of growth 
inhibition, while an unexpected result is the existence of massive 
microbial growth (no inhibition). 
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Figure 3. Five stages of biofilm development: (1) Initial attachment, (2) Irreversible 
attachment, (3) Maturation I, (4) Maturation II, and (5) Dispersion. Each stage of 
development in the diagram is paired with a photomicrograph of a developing P. 
aeruginosa biofilm. All photomicrographs are shown to same scale. 
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5. European legislation on veterinary drugs administered 
with drinking water. 
 
The EMA guideline 540/03 (CVMP) (24), consider that preparations as 
emulsions, granules, powders, concentrated solutions and suspensions 
may be administered to animals with drinking water, with regard to the 
following points: 
 possible excipients influence on the pH of the medicated water 
with consequent changes in solubility or stability of the active 
ingredient whose oral bioavailability would be altered; 
 thinness level of the powders and solubility of all ingredients 
regardless of the type of water distribution system; 
 the water solubility of the active ingredient at different 
temperatures and at different pH values; 
 the solubility of the active ingredient in water when are necessary 
pre-dilutions; 
 in case of powders, the solubilization have to take place in a 
reasonable time and that does not cause an excessive increase of 
the solution density; 
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 for emulsions must be evaluated the product dispersion at different 
pH values; 
 stability to the temperature;  
 duration of the product stability in water; 
 stability at different types of water (pH, temperature, hardness, 
salts, metals, etc.) and light. 
Therefore, the company that plans to market these pharmaceutical 
preparations will be required to perform various stability tests in relation 
to the aspects mentioned above. The results of these tests shall be printed 
on the label, so that who use the product can have clear indications. 
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6. Aim of the study 
 
In the food animal production, drinking water is frequently used as a way 
to carry out the most common pharmacological treatments. In these cases, 
there are many variables (for instance hardness, temperature, pH of the 
water and characteristics of mixing and distribution of the drugs) which 
could degrade drugs dissolved in this mean, even when properly arranged 
pharmaceutical formulations are used. In fact, although a product obtains 
a Marketing Authorization through appropriate laboratory studies both 
drug stability and solubility, on the other hand the solubility of the same 
drug in natural water used as a drinking water is not documented. This 
solution ability remains strictly linked to the variables inherent the 
drinking water characteristics. In the present study has been evaluated the 
dissolution kinetics (at 0 hours and 24 hours) of some common veterinary 
drugs used in drinking water samples in order to see how the different 
physical and chemical factors that characterize the drinking water may 
affect therapeutic efficacy. In fact, multiple factors, also of little 
relevance if individually considered, are able to adversely affect the 
pharmacological treatment carried out in drinking water. These factors 
combine to modify the active ingredients stability and/or solubility in 
drinking water, the formulation used and the excipients present as well. 
Moreover, being quite common the unaware use of expired products by 
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operators, some expired products (from 1 to 4 years) have been included 
in the experimental test. In this study were considered products having 
oxytetracycline and tylosin as active ingredient. Such molecules have 
pharmacological activity susceptible to degradation and/or reduction in 
their therapeutic efficacy if particular aspects of the drinking water are 
not considered or not known. 
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7. Materials and methods 
 
In the present study were randomly collected 9 drinking water samples in 
9 breeding farms distributed in 9 provinces of 5 Italian regions. 
Furthermore, to these 9 samples, were added other 2 samples: 1 sample of 
distilled water and 1 sample resulting from the mixing of distilled water 
with water sampled from the Bologna acqueduct in a ratio 1:1 (Table 7). 
All 11 water samples were analyzed in order to measure all the 
zoothecnical potability parameters at the Istituto Zooprofilattico 
Sperimentale della Lombardia ed Emilia Romagna "G. Ubertini" 
(IZSLER) Chemical Laboratories of Bologna.The technical tests related 
to the determination of zoothecnical potability parameters are shown in 
Tables 10, 11 and 12. Following this analysis, the samples 2, 4, 9, 10 and 
11 (renamed respectively 1, 2, 3, 4 and 5) were selected as water samples 
to be analyzed to the solubility test of some veterinary products having as 
active ingredient oxytetracycline, and tylosin (a macrolide for veterinary 
purposes only). 
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Samples Origin Farm Region/Province 
01 Acqueduct Swine Veneto (TV) 
02 Acqueduct Rabbits Emilia Romagna (FC) 
03 Acqueduct Poultry Emilia Romagna (BO) 
04 Well Swine Puglia (FG) 
05 Well Rabbits Campania (CE) 
06 Well Swine Lombardia (BS) 
07 Well Rabbits Lombardia (MN) 
08 Well Swine Piemonte (CN) 
09 Lake Poultry Emilia Romagna (RN) 
10 Distilled /// /// 
11 
Acqueduct:distilled 
(50:50) 
/// Emilia Romagna (BO) 
Table 7. Water samples origin. 
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The 6 products oxytetracycline based were identified respectively A, B, 
C, D, E, F and showed the characteristics indicated in Table 8. 
 
ID A. I. Pharm. form Expired 
OTC-A OTC 20% LIQUID 4 YEARS 
OTC-B OTC 20% LIQUID 2 YEARS 
OTC-C OTC 20% POWDER NO 
OTC-D OTC 20% LIQUID 3 YEARS 
OTC-E OTC 20% POWDER NO 
OTC-F OTC 20% LIQUID 1 YEAR 
Table 8. Characteristics of based-oxytetracycline products. 
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The 6 products based on tylosin were identified respectively A, B, C, D, 
E, F and showed the characteristics indicated in Table 9. 
 
ID A. I. Pharm. form Expired 
TYL-A TYL 100% POWDER  NO 
TYL-B TYL 100% POWDER NO 
TYL-C TYL 20% LIQUID 1 YEAR 
TYL-D TYL 20% LIQUID 1 YEAR 
TYL-E TYL 20% LIQUID NO 
TYL-F TYL 20% LIQUID NO 
Table 9. Characteristics of based-tylosin products. 
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In the case of products based on 20% of oxytetracycline, assuming that 
the expected dosage for avian species is 50 mg of A.I. per kg of body 
weight and calculating that for a broiler weighting about 3 Kg the water 
consumption is about 100ml/Kg of B.W./day, were dissolved 50 mg of 
A.I. (corresponding to 250 mg of product) of the C product in 5 Becker 
(identified from C1 to C5) containing 100 ml of each water sample 
selected. Simultaneously, the same method was followed for the other 5 
products remaining (A, B, D, E and F).  
Each Becker was then stirred manually until complete dissolution. Then, 
from each Becker 1 mL of solution was taken and repeatedly diluted until 
to obtain a concentration of 100 ng/ml. Then, the tubes containing the 
obtained solutions were capped and vortexed for about 1 minute. From 
each tube 2 mL of solution were collected and placed in vials for the LC-
MS/MS detection.  
The standard was dissolved in methanol and then diluted in distilled 
water until obtaining a 100 ng/ml concentration following the same 
process used for products samples. After 24 hours, 1 mL of solution was 
collected from each Becker and repeatedly diluted until to obtain a 
concentration of 100 ng/ml.  
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Finally, the tubes containing the obtained solutions were capped and 
vortexed for about 1 minute. From each tube 2 mL of solution were 
collected and placed in vials for the LC-MS/MS detection.  
Similarly, for products based on 20% of tylosin, assuming that the 
expected dosage for avian species is 25 mg of A.I. per kg of body weight 
and calculating that for a broiler weighting about 3 Kg the water 
consumption is about 100ml/Kg of B.W./day, were diluted 25 mg of A.I. 
(corresponding to 125 mg of product) mg of the product C in 5 Becker 
(identified from C1 to C5) containing 100 ml of each water sample 
selected. Simultaneously, the same method was followed for the other 5 
products (D, E and F). About the remaining products A and B, based on 
100% of tylosin, assuming that the expected dosage for avian species is 
25 mg of A.I. per kg of body weight and calculating that for a broiler 
weighting about 3 Kg the water consumption is about 100ml/Kg of 
B.W./day, were diluted 25 mg of A.I. (corresponding to 25 mg of 
product) mg of the product A in 5 Becker (identified from A1 to A5) 
containing 100 ml of each water sample selected. Simultaneously, the 
same method was followed for the other product remaining (B). 
Each Becker was then stirred manually until complete dissolution. Then, 
from each Becker 1 mL of solution was taken and repeatedly diluted until 
to obtain a concentration of 100 ng/ml. Then, the tubes containing the 
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obtained solutions were capped and vortexed for about 1 minute. From 
each tube 2 mL of solution were collected and placed in vials for the LC-
MS/MS detection.  
The standard was dissolved in methanol and then diluted in distilled 
water until obtaining a 100 ng/ml concentration following the same 
process used for products samples. After 24 hours, 1 mL of solution was 
collected from each Becker and repeatedly diluted until to obtain a 
concentration of 100 ng/ml.  
Finally, the tubes containing the obtained solutions were capped and 
vortexed for about 1 minute. From each tube 2 mL of solution were 
collected and placed in vials for the LC-MS/MS detection.  
All the samples derived by the based-oxytetracycline and based-tylosin 
products solubilization in 5 samples of water selected after the 
determination of the zootechnical potability parameters, were analyzed in 
a Waters Alliance 2795 HPLC system (Milford MA USA) with Synergy 
Polar column (2.0mmx150mm; 4 micron) (Phenomenex USA), coupled 
to a mass spectrometer Four Last Platinum (Micromass Manchester UK).  
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8. Results 
 
In determining the zootechnical potability parameters relevant differences 
were not found between the nine water samples taken from different 
farms but consequently this analysis, the samples 2, 4, 9, 10 and 11 
(renamed respectively 1, 2, 3, 4 and 5) were selected and they were used 
to carry out the solubility test of the products. The water samples 
characteristics are described in tables 10, 11 and 12. 
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DRINKING WATER SAMPLES 
TEST 1 2 3 4 
pH  7,7 7,9 7,3 7,9 
Chlorine residual 
free 
<0,01 mg/l <0,01 mg/l <0,01 mg/l <0,01 mg/l 
Oxydability <0,02 mg/l di O2 0,48 mg/l di O2 <0,02 mg/l di O2 0,24 mg/l di O2 
Hardness 18 FD 21,5 FD 17,5 FD 14,5 FD 
Total dissolved 
Solids at 180° C 
160 mg/l 221 mg/l 387 mg/l 150 mg/l 
Nitrites <0,05 mg/l <0,05 mg/l <0,05 mg/l <0,05 mg/l 
Nitrates 3 mg/l 4,5 mg/l 4,6 mg/l 3,2 mg/l 
Colour 0 Hazen 0 Hazen 0 Hazen 0 Hazen 
Conductivity 385 µS/cm 444 µS/cm 596 µS/cm 371 µS/cm 
Chlorides 3,2 mg/l 16,9 mg/l 19,2 mg/l 6,1 mg/l 
Sulphites 31,8 mg/l 22,2 mg/l 56,5 mg/l 2,9 mg/l 
Ammonia <0,1 mg/l <0,1 mg/l <0,1 mg/l <0,1 mg/l 
Phosphorus <70 µg P2O5/l <70 µg P2O5/l <70 µg P2O5/l <70 µg P2O5/l 
Iron <0,01 mg/l <0,01 mg/l <0,01 mg/l <0,01 mg/l 
Calcium 83,6 mg/l 86,1 mg/l 136,4 mg/l 80,4 mg/l 
Table 10. Zootchenical potability parameters analysis results for samples 1-4.  
In red, results of samples 2 and 4 selected for the dissolution test. FD: French degrees. 
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DRINKING WATER SAMPLES 
TEST 5 6 7 8 
pH  7,2 8,0 7,9 7,1 
Chlorine residual 
free 
<0,01 mg/l <0,01 mg/l <0,01 mg/l <0,01 mg/l 
Oxydability <0,02 mg/l di O2 1,36 mg/l di O2 0,28 mg/l di O2 <0,02 mg/l di O2 
Hardness 16,5 FD 23 FD 22 FD 20,5 FD 
Total dissolved 
Solids at 180° C 
220 mg/l 174 mg/l 211 mg/l 406 mg/l 
Nitrites <0,05 mg/l 0,12 mg/l <0,05 mg/l <0,05 mg/l 
Nitrates 5,2 mg/l <1 mg/l 1,3 mg/l 30,9 mg/l 
Colour 0 Hazen 20 Hazen 0 Hazen 0 Hazen 
Conductivity 409 µS/cm 392 µS/cm 427 µS/cm 589 µS/cm 
Chlorides 14,8 mg/l 2 mg/l 2,4 mg/l 7 mg/l 
Sulphites 1,5 mg/l <1 mg/l <1 mg/l 43,7 mg/l 
Ammonia <0,1 mg/l 2 mg/l 0,1 mg/l <0,1 mg/l 
Phosphorus <70 µg P2O5/l <70 µg P2O5/l <70 µg P2O5/l <70 µg P2O5/l 
Iron <0,01 mg/l 0,5 mg/l 0,28 mg/l <0,01 mg/l 
Calcium 68,1 mg/l 88,4 mg/l 103 mg/l 154,4 mg/l 
Table 11. Zootchenical potability parameters analysis results for samples 5-8. FD: 
French degrees. 
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DRINKING WATER SAMPLES 
TEST 9 10 11 
pH  8,4 7,2 7,3 
Chlorine residual free <0,01 mg/l <0,01 mg/l <0,01 mg/l 
Oxydability 4,88 mg/l di O2 <0,02 mg/l di O2 <0,02 mg/l di O2 
Hardness 30 FD <0,5 FD 20 FD 
Total dissolved Solids at 
180° C 
649 mg/l 0 mg/l 166 mg/l 
Nitrites 0,06 mg/l <0,05 mg/l <0,05 mg/l 
Nitrates 3,5 mg/l <1 mg/l 2,7 mg/l 
Colour 20 Hazen 0 Hazen 0 Hazen 
Conductivity 768 µS/cm 5,69 µS/cm 370 µS/cm 
Chlorides 37,9 mg/l 1,5 mg/l 10,5 mg/l 
Sulphites 180,5 mg/l <1 mg/l 28,9 mg/l 
Ammonia 0,2 mg/l <0,1 mg/l <0,1 mg/l 
Phosphorus <70 µg P2O5/l <70 µg P2O5/l <70 µg P2O5/l 
Iron <0,03 mg/l <0,01 mg/l <0,01 mg/l 
Calcium 81,4 mg/l <0,1 mg/l 69,7 mg/l 
Table 12. Zootchenical potability parameters analysis results for samples 
9-11. In red, results of samples 9, 10 and 11 selected for the dissolution 
test. FD: French degrees. 
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The oxytetracycline concentrations obtained both at 0 h and after 24 h are 
described in tables 13-14 and in graphics 1-12. 
 
 1 2 3 4 5 
 
pH 7.96 
FD 21.5 
pH 7.94 
FD 14.5 
pH 8.40 
FD 30.0 
pH 7.22 
FD <0.5 
pH 7.31 
FD 20.0 
OTC A 35 37 35 36 23 
OTC B 66 64 61 53 61 
OTC C 135 145 139 142 132 
OTC D 30 41 40 27 14 
OTC E 124 127 80 118 83 
OTC F 88 55 87 84 77 
Table 13. Oxytetracycline concentrations in ng/ml at 0h. FD: French degrees. 
 
 1 2 3 4 5 
 
pH 7.96 
FD 21.5 
pH 7.94 
FD 14.5 
pH 8.40 
FD 30.0 
pH 7.22 
FD <0.5 
pH 7.31 
FD 20.0 
OTC A 7 6 6 20 9 
OTC B 16 8 11 16 9 
OTC C 40 84 89 37 95 
OTC D 6 9 8 15 11 
OTC E 53 88 51 49 80 
OTC F 33 49 33 23 32 
Table 14. Oxytetracycline concentrations in ng/ml at 24h. FD: French degrees. 
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The solubility differences of based-oxytetraycline products registered at 
0h and 24h, expressed as percentage changes of solubility at 0h and 24h 
(product concentration at 24h/product concentration at 0h * 100), are 
described both in table 15 and in graphics 25-30. 
 
 
1 2 3 4 5 
pH 7.96 
FD 21.5 
pH 7.94 
FD 14.5 
pH 8.40 
FD 30.0 
pH 7.22 
FD <0.5 
pH 7.31 
FD 20.0 
OTC A 20 16 17 56 39 
OTC B 24 13 18 30 15 
OTC C 30 58 64 26 72 
OTC D 20 22 20 56 79 
OTC E 43 69 64 42 96 
OTC F 38 89 38 27 42 
Table 15. Solubility differences of based-oxytetraycline products registered at 0h and 
24h (expressed in percentage). FD: French degrees. 
 
The tylosin concentrations obtained both at 0 h and after 24 h are 
described in tables 16-17 and in graphics 13-24. 
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 1 2 3 4 5 
 
pH 7.96 
FD 21.5 
pH 7.94 
FD 14.5 
pH 8.40 
FD 30.0 
pH 7.22 
FD <0.5 
pH 7.31 
FD 20.0 
TYL A 71 70 73 67 75 
TYL B 65 51 60 68 59 
TYL C 36 22 18 21 33 
TYL D 19 18 23 34 20 
TYL E 16 22 38 22 19 
TYL F 21 34 19 18 22 
Table 16. Tylosin concentrations in ng/ml at 0h. FD: French degrees. 
 
 
 1 2 3 4 5 
 
pH 7.96 
FD 21.5 
pH 7.94 
FD 14.5 
pH 8.40 
FD 30.0 
pH 7.22 
FD <0.5 
pH 7.31 
FD 20.0 
TYL A 59 56 53 53 65 
TYL B 51 42 48 60 44 
TYL C 40 37 43 39 38 
TYL D 32 25 24 26 25 
TYL E 20 24 20 25 22 
TYL F 36 28 23 24 25 
Table 17. Tylosin concentrations in ng/ml at 24h. FD: French degrees. 
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The solubility differences of based-tylosin products registered at 0h and 
24h, expressed as percentage changes of solubility at 0h and 24h (product 
concentration at 24h/product concentration at 0h * 100), are described 
both in table 18 and in graphics 31-36. 
 
 
1 2 3 4 5 
pH 7.96 
FD 21.5 
pH 7.94 
FD 14.5 
pH 8.40 
FD 30.0 
pH 7.22 
FD <0.5 
pH 7.31 
FD 20.0 
TYL A 83 80 73 79 87 
TYL B 78 82 80 88 75 
TYL C 111 168 239 186 115 
TYL D 168 139 104 76 125 
TYL E 125 109 53 114 116 
TYL F 171 82 121 133 114 
Table 18. Solubility differences of based-tylosin products registered at 0h and 24h 
(expressed in percentage). FD: French degrees. 
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Graphic 1. OTC A concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 2. OTC A concentrations at 24h (ng/ml). 
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Graphic 3. OTC B concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 4. OTC B concentrations at 24h (ng/ml). 
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Graphic 5. OTC C concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 6. OTC C concentrations at 24h (ng/ml). 
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Graphic 7. OTC D concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 8. OTC D concentrations at 24h (ng/ml). 
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Graphic 9. OTC E concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
Graphic 10. OTC E concentrations at 24h (ng/ml). 
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Graphic 11. OTC F concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
Graphic 12. OTC F concentrations at 24h (ng/ml). 
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Graphic 13. TYL A concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 14. TYL A concentrations at 24h (ng/ml). 
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Graphic 15. TYL B concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 16. TYL B concentrations at 24h (ng/ml). 
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Graphic 17. TYL C concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
Graphic 18. TYL C concentrations at 24h (ng/ml). 
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Graphic 19. TYL D concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
Graphic 20. TYL D concentrations at 24h (ng/ml). 
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Graphic 21. TYL E concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 22. TYL E concentrations at 24h (ng/ml). 
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Graphic 23. TYL F concentrations at 0h (ng/ml). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 24. TYL F concentrations at 24h (ng/ml). 
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Graphic 25. OTC A product solubility differences at 0h/24h (in percentage). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 26. OTC B product solubility differences at 0h/24h (in percentage). 
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Graphic 27. OTC C product solubility differences at 0h/24h (in percentage). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 28. OTC D product solubility differences at 0h/24h (in percentage). 
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Graphic 29. OTC E product solubility differences at 0h/24h (in percentage). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 30. OTC F product solubility differences at 0h/24h (in percentage). 
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Graphic 31. TYL A product solubility differences at 0h/24h (in percentage). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 32. TYL B product solubility differences at 0h/24h (in percentage). 
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Graphic 33. TYL C product solubility differences at 0h/24h (in percentage). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 34. TYL D product solubility differences at 0h/24h (in percentage). 
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Graphic 35. TYL E product solubility differences at 0h/24h (in percentage). 
 
 
 
 
 
 
 
 
 
 
 
Graphic 36. TYL F product solubility differences at 0h/24h (in percentage). 
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Graphic 37. Oxytetracycline products concentrations at 0h (ng/ml). Characteristics of water samples identified from 1 
to 5: Water ID 1 pH 7.96 FD 21.5; Water ID 2 pH 7.94 FD 14.5; Water ID 3 pH 8.40 FD 30.0; Water ID 4 pH 7.22 FD 
<0.5; Water ID 5 pH 7.31 FD 20.0. 
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Graphic 38. Oxytetracycline products concentrations at 24h (ng/ml). Characteristics of water samples identified from 1 
to 5: Water ID 1 pH 7.96 FD 21.5; Water ID 2 pH 7.94 FD 14.5; Water ID 3 pH 8.40 FD 30.0; Water ID 4 pH 7.22 FD 
<0.5; Water ID 5 pH 7.31 FD 20.0. 
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Graphic 39. Tylosin products concentrations at 0h (ng/ml). Characteristics of water samples identified from 1 to 5: 
Water ID 1 pH 7.96 FD 21.5; Water ID 2 pH 7.94 FD 14.5; Water ID 3 pH 8.40 FD 30.0; Water ID 4 pH 7.22 FD <0.5; 
Water ID 5 pH 7.31 FD 20.0. 
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Graphic 40. Tylosin products concentrations at 24h (ng/ml). Characteristics of water samples identified from 1 to 5: 
Water ID 1 pH 7.96 FD 21.5; Water ID 2 pH 7.94 FD 14.5; Water ID 3 pH 8.40 FD 30.0; Water ID 4 pH 7.22 FD <0.5; 
Water ID 5 pH 7.31 FD 20.0. 
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Graphic 41. Box plot displaying the based-oxytetracycline products 
distribution. 
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Graphic 42. Strip plot displaying every observation point of based-
oxytetracycline products. 
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Graphic 43. Box plot displaying the based-tylosin products 
distribution. 
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Graphic 44. Strip plot displaying every observation point of based-
tylosin products. 
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Graphic 45. pH and based-oxytetracycline products. 
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Graphic 46. pH and based-tylosin products. 
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Graphic 47. Oxydability and based-oxytetracycline products. 
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Graphic 48. Oxydability and based-tylosin products. 
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Graphic 49. Hardness and based-oxytetracycline products. 
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Graphic 50. Hardness and based-tylosin products. 
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Graphic 51. Nitrates and based-oxytetracycline products. 
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Graphic 52. Nitrates and based-tylosin products. 
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Graphic 53. Conductivity and based-oxytetracycline products. 
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Graphic 54. Conductivity and based-tylosin products. 
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Graphic 55. Chlorides and based-oxytetracycline products. 
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Graphic 56. Chlorides and based-tylosin products. 
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Graphic 57. Sulphates and based-oxytetracycline products. 
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Graphic 58. Sulphates and based-tylosin products. 
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Graphic 59. Total dissolved Solids at 180° C and based-oxytetracycline 
products. 
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Graphic 60. Total dissolved Solids at 180° C and based-tylosin products. 
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Graphic 61. Calcium and based-oxytetracycline products. 
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Graphic 62. Calcium and based-tylosin products. 
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9. Discussion and Conclusion  
 
The water samples used in this experimental test reflect, in their own 
diversity, the heterogeneity of water used to dissolve pharmaceutical 
products in breeding farms; there are a large number of water samples 
intrinsic variables that may affect the drugs solubility that was the 
objective of this experimental trial.  
The graphs 37, 38, 41, 42 show the based-oxytetracycline products 
dissolution in different water samples at 0h and 24h respectively, as well 
as the variability associated to the different determinations. For all based-
oxytetracycline products considered, it was possible to observe a 
tendency to decrease in solubility between 0h and 24 h. In fact, for the 
different products, at 24h, active ingredient percentages between 20 and 
62.8% (compared to that ones detected at 0h) were observed. The already 
expired products (OTC A, OTC B, OTC D and OTC F) showed active 
ingredient concentrations much lower as they were far from the 
expiration date. This occurrence has been noticed in all water samples 
analyzed both at 0 hours and at 24 hours. After 24 hours, in 4 products 
expired liquids OTC A, OTC B, OTC D and OTC F, it was possible to 
detect an oxytetracycline average percentage of 33.9% compared to that 
one detected at 0h. At 24 h, the not expired products (OTC C and OTC E) 
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showed an active ingredient average of 56.3% compared with that one 
rileved at 0h so maintaining a higher over time. 
At 0h it was possible to observe how some products (OTC A, B OTC, 
OTC C) were less affected by the water effect: there was a lower results 
dispersion but in other cases (OTC E) the variability was higher. In the 
OTC E case, the variability even in the determinations carried out at 24h 
was maintained, as well as the variability lack of OTC A and OTC B 
products over 24 hours was maintained. The OTC C product had an 
intermediate situation, with little variability at 0h and increased 
determinations variability at 24h from dissolution. 
The graphs 39, 40, 43, 44 show the based-tylosin products dissolution in 
different water samples at 0h and 24h respectively, as well as the 
variability associated to the different determinations. About the based-
tylosin products, the results were different. In fact, for some products was 
possible to observe a trend of solubility increase between 0h and 24h 
results. At 24h, for all based-tylosn different products, active ingredient 
percentages between 80% and 164% (compared to that ones detected at 
0h) were detected. At 0h it was possible to observe how some products 
(TYL D, TYL E, TYL F) were less affected by the water effect: there was 
a lower results dispersion but in other cases (TYL C) the variability was 
higher. In the case of TYL D, TYL E, TYL F such variability even in 
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determinations carried out at 24h was maintained. In contrast, TYL C 
variability decreases at 24 hours. In 24 hours, all these products showed 
solubility increase. The in liquid form TYL C, TYL D, TYL E and TYL 
F based-tylosin products (only 2 over expiration date), at 0h showed 
active principle concentrations lower than those registered at 24h. In fact, 
after 24 hours it was possible to detect a tylosin percentage average of 
128.5% compared to that one detected at 0h. These results could be 
occurred because of the low and slow solubility of these products in all 5 
water samples selected. The TYL A and TYL B products (in powder 
form) showed variability intermediate and similar results both at 0h and 
at 24h, with a tendency to decrease in solubility; after 24h for TYL A and 
TYL B products active principle percentages of 80.4% and 80.6% 
(compared to that one detected at 0h) respectively were detected.  
The graphs 45-62 show how the intrinsic characteristics of the water such 
as pH, hardness, conductivity and calcium may affect the dissolution of 
drugs tested in water. The results suggest that it would be appropriate to 
test the products in water samples under challenging conditions 
dissolution, in order to identify in advance possible problems. 
In general, is possible to conclude that powder products showed a best 
dissolution kinetics then liquid form products. 
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Finally the data obtained in this study show how the water quality is 
critical for the therapeutic success, especially in light of the growing use 
of water as vehicle for immunological treatments. In effect, as requested 
by the Summary Product Characteristics of these vaccines, a good quality 
of the water is crucial for the proper functioning of the immunological 
products dissolved in. Therefore, data obtained in the present study may 
represent a starting point for further investigations, bearing in mind that a 
drugs poor solubility in drinking water can cause beyond a lower efficacy 
of treatments, an antibiotic-resistance increase, episodes of toxicity, 
problems to water distribution systems, drug residues presence and finally 
environmental pollution.  
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